Building better base editors

VIB scientists develop ITER, a sensitive, versatile, and high-throughput method to test and quantify gene editing in plant cells

CRISPR gene editing is a powerful biotechnology tool that allows scientists to alter specific DNA sequences. New research is constantly refining and improving CRISPR technology. Researchers from the team of Prof. Thomas Jacobs (VIB-UGent Center for Plant Systems Biology), together with BASF Innovation Center Gent and colleagues from the VIB screening Core and VIB Flow Core, now report an important advance in CRISPR base editing technology. Their work was funded by VLAIO and appears in Genome Biology.

The scientific world was rocked in 2012 by the development of CRISPR gene-editing tools using the DNA-cutting protein Cas9, an advance that received a Nobel Prize in 2020. CRISPR technology now has applications all across the biological sciences, from improving the crops we rely on to use in medicine treating sickle cell disease, cancer, and other diseases.

The original CRISPR technology from a decade ago did have some limitations. For instance, it was not very easy to control the types of DNA changes that were being made. The development of ‘base editors’ in 2016 changed all of that. CRISPR base editors are particularly powerful as they can replace one specific DNA base (a DNA ‘letter’) with another allowing for very precise changes in the DNA sequence.

Prof. Thomas Jacobs: “When we started the project, there were a few problems with the existing CRISPR base editors. The first was that they didn’t work that well. Only a quarter of our targets were edited. The second was that, by then, there was a large number of different CRISPR parts. Using our existing methods to test and evaluate all of the different combinations to find the best one would take too much time. So, we developed ITER.”

ITER, or Iterative Testing of Editing Reagents, is a sensitive, versatile, and high-throughput method to test and quantify gene editing in plant cells. It is a way to simultaneously test many potential base editors in many cells. A fully automated imaging and analysis pipeline allows the researchers to rapidly test the different editors and design the next experiment. Each iteration only takes a few weeks to complete, so optimization proceeds quickly.

In the first use of ITER, the researchers identified a variant of Cas12a (an alternative DNA-cutting protein) that efficiently performs base editing in wheat and maize cells. The first Cas12a base editors only edited about one in 200 cells. But by rapidly performing multiple rounds of testing with ITER, they were able to increase editing efficiency to about 40%.

Dr. Christophe Gaillochet, first author of the study: “Especially in plants, this improvement is a great step forward, not only because previous base editors with Cas12a didn’t perform well, but also because it gives us a much better tool for plant breeding to make our crops more resilient to challenging environments caused by climate change.”

The team is now using ITER to optimize different types of genome editing tools in a variety of plant species.


Publication

Systematic optimization of Cas12a base editors in wheat and maize using the ITER platform. Gaillochet et al. Genome Biology, 2023.


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

Share

Latest stories

Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be
Website preview
Brain immune cells may help build Alzheimer’s plaques
A new study led by researchers from VIB and KU Leuven shows that immune cells called microglia can actively promote the formation of plaques in Alzheimer’s disease, challenging the long-standing view that these cells serve only as defenders against plaque buildup. The findings were recently published in PNAS.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be